Prostaglandin E Receptor EP4 expression, survival and pattern of recurrence in locally advanced NSCLC
Author:
Funder
P.J. Aldridge Foundation
Publisher
Elsevier BV
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference25 articles.
1. Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer;Ristimaki;Cancer Res.,2002
2. COX-2 activation is associated with Akt phosphorylation and poor survival in ER-negative, HER2-positive breast cancer;Glynn;BMC Cancer,2010
3. Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small-cell lung cancer;Khuri;Clin. Cancer Res.,2001
4. Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib+ chemotherapy–Cancer and Leukemia Group B Trial 30203;Edelman;J. Clin. Oncol.,2008
5. Targeting cyclooygenase-2 in recurrent non-small cell lung cancer: a phase II trial of celecoxib and docetaxel;Csiki;Clin. Cancer Res.,2005
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Natural fulvic acids inhibit non-small-cell lung cancer through the COX-2/PGE2/EP4 axis: In silico and in vivo assessments;Heliyon;2023-06
2. Prostaglandin E2 Receptor 4 (EP4): A Promising Therapeutic Target for the Treatment of Cancer and Inflammatory Diseases;Current Chemical Biology;2021-04-27
3. Prostanoid Receptors of the EP4-Subtype Mediate Gene Expression Changes in Human Airway Epithelial Cells with Potential Anti-Inflammatory Activity;Journal of Pharmacology and Experimental Therapeutics;2020-11-06
4. EP4 and Class III β-Tubulin Expression in Uterine Smooth Muscle Tumors: Implications for Prognosis and Treatment;Cancers;2019-10-18
5. Reciprocal interaction of HOTAIR and SP1 together enhance the ability of Xiaoji decoction and gefitinib to inhibit EP4 expression;Journal of Ethnopharmacology;2019-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3